ダウン症における白血病の細胞起源と早期の進化のマッピング
Elvin Wagenblast1, Joana Araújo2,3,4,5,6, Olga I Gan2
1Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada. elvin.wagenblast@uhnresearch.ca john.dick@uhnresearch.ca eric.lechman@uhnresearch.ca.
まとめ
ダウン症の子供は 骨髄性白血病のリスクが高くなります 遺伝子編集により,GATA1変異がトリソミー21の細胞における白血病前発症を引き起こすことが明らかになったが,白血病の進行にはコヘシン遺伝子変異が関与し,トリソミー21とは独立している.
科学分野:
- 血液学
- 遺伝学
- 発達生物学
背景:
- ダウン症候群の子供は,骨髄性白血病を発症するリスクが著しく高まっている (150倍).
- ダウン症の患者に白血病を誘発する根本的なメカニズムは完全に理解されていません.
- ダウン症候群における白血病発生は胎児の発達に起因し,早期の細胞および発達要因の調査を必要とします.
研究 の 目的:
- ダウン症候群における白血病前発症と白血病進行の細胞および発達的背景を解明する.
- ダウン症の白血病発生におけるGATA結合タンパク質1 (GATA1) 変異と染色体21のマイクロRNAの役割を調査する.
- 白血病の進行を促す要因と潜在的な治療標的を特定する.
主な方法:
- ヒトのジソミックおよびトライソミック胎児の血液生成細胞の遺伝子編集を活用した.
- 前白血病と白血病の発達を研究するために,異種移植モデルを使用した.
- GATA1変異と染色体21のマイクロRNAが血液形成幹細胞に与える影響を分析した.
主要な成果:
- GATA1変異は,21染色体マイクロRNAのサブセットが傾向に影響を及ぼし,トリソミー21染色体幹細胞における一時的な白血病を誘発した.
- 白血病の進行はトリソミー21とは無関係で,コヘシン遺伝子の追加の突然変異を被った様々な幹細胞および祖先細胞から生じた.
- CD117+/ KIT+細胞は,白血病前と白血病の両方の増殖における重要な媒介体として特定されました.
結論:
- ダウン症候群の罹患傾向は,早期発達の過程でGATA1変異と染色体21マイクロRNAを含む.
- 白血病の進行は,トリソミー21の状態に関係なく,コヘシン遺伝子の二次変異によって引き起こされます.
- KIT+細胞を標的とした治療は,ダウン症候群に関連した骨髄性白血病の治療の可能性を示しています.
関連する概念動画
Karyotyping
64.4K
Overview
64.4K
Differentiation of Common Myeloid Progenitor Cells
3.6K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.6K
Cancers Originate from Somatic Mutations in a Single Cell
13.3K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.3K
Disorders of Leukocytes
1.4K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.4K
Meiosis vs. Mitosis
62.9K
Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
62.9K


